Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pflügers Archiv: European Journal of Physiology

• Publication date

  2014-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00424-014-1596-xPMID 25132355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier

  2013cited by this paper
• The SLCO (former SLC21) superfamily of transporters.

  2013influential reference
• Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues.

  2012cited by this paper
• Dehydroepiandrosterone Sulphate: Action and Mechanism in the Brain

  2012cited by this paper
• Functions of OATP1A and 1B transporters in vivo: insights from mouse models.

  2012cited by this paper
• Expression of thyroid hormone transporters in the human hypothalamus.

  2011cited by this paper
• Neurosteroids and GABAA Receptor Interactions: A Focus on Stress

  2011cited by this paper
• Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

  2010cited by this paper
• Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

  2009cited by this paper
• Role of retinal glial cells in neurotransmitter uptake and metabolism.

  2009cited by this paper
• Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.

  2009cited by this paper
• Neurosteroid Biosynthesis Regulates Sexually Dimorphic Fear and Aggressive Behavior in Mice

  2008cited by this paper
• Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier.

  2008cited by this paper
• Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.

  2008cited by this paper
• Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

  2008influential reference
• Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain.

  2007cited by this paper
• CHARACTERIZATION OF TWO SPLICE VARIANTS OF HUMAN ORGANIC ANION TRANSPORTING POLYPEPTIDE 3 A 1 ( OATP 3 A 1 ) ISOLATED FROM HUMAN BRAIN

  2006influential reference
• Modification of OATP2B1-Mediated Transport by Steroid Hormones

  2006cited by this paper
• Pharmacogenomics of human OATP transporters

  2006cited by this paper
• Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.

  2006cited by this paper
• Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium.

  2005cited by this paper
• Cloning, transport properties, and differential localization of two splice variants of GLT‐1 in the rat CNS: Implications for CNS glutamate homeostasis

  2004cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• Differential expression of GFAP in early v late AMD: a quantitative analysis

  2003cited by this paper
• Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier

  2003cited by this paper
• Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye.

  2003cited by this paper
• Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats.

  2003cited by this paper
• Immunoreactive substance P is not part of the retinohypothalamic tract in the rat

  2002cited by this paper
• Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina.

  2002cited by this paper
• Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.

  2002cited by this paper
• Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta.

  2002cited by this paper
• Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium.

  2002influential reference
• Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina.

  2001cited by this paper
• Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver.

  2001cited by this paper
• Glyt‐1 expression in cultured human Müller cells and intact retinae

  2001cited by this paper
• Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.

  2001influential reference
• Neurosteroid synthesis by cytochrome p450-containing systems localized in the rat brain hippocampal neurons: N-methyl-D-aspartate and calcium-dependent synthesis.

  2001cited by this paper
• Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver

  2001cited by this paper
• Regulation of glutamate transporters in health and disease.

  2001cited by this paper
• Substance p.

  2001cited by this paper
• Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells.

  2000cited by this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000influential reference
• Expression, transport properties, and chromosomal location of organic anion transporter subtype 3.

  2000cited by this paper
• Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate.

  2000cited by this paper
• Age-related Macular Degeneration

  2000cited by this paper
• Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.

  1999cited by this paper
• Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver.

  1999cited by this paper
• Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain

  1999cited by this paper
• Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain

  1998influential reference
• The choroid plexus epithelium is the site of the organic anion transport protein in the brain.

  1997cited by this paper
• Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX

  1997cited by this paper
• Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain.

  1997cited by this paper
• Neurotransmitters in the retina.

  1996cited by this paper
• Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver.

  1995influential reference
• Glycine transporters are differentially expressed among CNS cells

  1995cited by this paper
• Substance P‐immunoreactive neurons in the human retina

  1995cited by this paper
• Neurosteroidogenesis in Rat Retinas

  1994cited by this paper
• Expression cloning of a rat liver Na(+)-independent organic anion transporter.

  1994cited by this paper
• Localization of GABA, glycine, glutamate and tyrosine hydroxylase in the human retina

  1992influential reference
• Substance-P-like immunoreactive amacrine cells in the adult and the developing rat retina.

  1992cited by this paper
• Localization of neuropeptide-immunoreactive neurons in the human retina.

  1990cited by this paper
• Localization of neuropeptide-immunoreactive neurons in the human retina.

  1990cited by this paper
• Expression and cellular localization of substance P/neurokinin A and neurokinin B mRNAs in the rat retina

  1989cited by this paper
• Vasoactive intestinal peptide

  1989cited by this paper
• Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11).

  1989cited by this paper
• Neuropeptide Y-like immunoreactivity in neurons of the human retina.

  1989cited by this paper
• Localization of angiotensin converting enzyme in the ciliary epithelium of the rat eye.

  1989cited by this paper
• Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.

  1988cited by this paper
• Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology.

  1988cited by this paper
• Peptide immunoreactive neurons in the human retina.

  1988cited by this paper
• Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism.

  1987influential reference
• Neurosteroids: cytochrome P-450scc in rat brain.

  1987cited by this paper
• Substance P in the human brain.

  1986cited by this paper
• An immunohistochemical study of endopeptidase-24.11 ("enkephalinase") in the pig nervous system.

  1986cited by this paper
• Early development of tyrosine hydroxylase-like and substance P-like immunoreactivity in the human fetal retina.

  1986cited by this paper
• Vasoactive intestinal peptide.

  1986cited by this paper
• Endopeptidase-24.11 'enkephalinase': its role in the central nervous system.

  1985cited by this paper
• The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

  1984cited by this paper
• Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway.

  1984cited by this paper
• L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas.

  1983cited by this paper

• A stimuli-responsive mitochondria-targeted nanoplatform for glioblastoma therapy: modulating the blood-brain barrier and delivering precise chemotherapy.

  2026cites this paper
• In vivo evidence of functional OATP2B1 activity in human skeletal muscle using [11C]erlotinib PET.

  2026cites this paper
• Atherosclerosis enhances the efficacy of liposome-encapsulated bromocriptine in reducing the incidence of prolactinemia in pituitary tumors

  2025cites this paper
• In vitro human brain barrier models for studying thyroid hormone transport

  2025cites this paper
• Unraveling the Mode of Action of a Neuron-Specific Fluorescent Probe, NeuO: Intracellular Phosphorylation Through PAK6 Kinase.

  2025cites this paper
• Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier.

  2025cites this paper
• In Vitro Evaluation of the Potential Interactions of Zearalenone-14-sulfate and Zearalenone-14-glucuronide with Human Cytochrome P450 Enzymes, Organic Anion Transporting Polypeptides, and ATP-Binding Cassette Multidrug Transporters

  2025cites this paper
• Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier

  2025cites this paper
• Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey

  2025cites this paper
• Targeted and Untargeted Proteomics-based Comparison of Adenoviral Infected hCMEC/D3 and hBMEC as a Human Brain Endothelial Cells to Study the OATP2B1 Transporter

  2025cites this paper
• Proteome profile differences among human, monkey, and mouse brain microvessels and cultured brain microvascular endothelial cells

  2025cites this paper
• In Vitro Characterization of SLCO2B1 Genetic Variants.

  2025cites this paper
• Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review.

  2024cites this paper
• The macrocycle inhibitor landscape of SLC‐transporter

  2024cites this paper
• Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

  2024cites this paper
• The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites.

  2024cites this paper
• Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study

  2024cites this paper
• Drugs in Human Milk Part 1: Practical and Analytical Considerations in Measuring Drugs and Metabolites in Human Milk

  2024cites this paper
• Interaction of mycotoxins zearalenone, α-zearalenol, and β-zearalenol with cytochrome P450 (CYP1A2, 2C9, 2C19, 2D6, and 3A4) enzymes and organic anion transporting polypeptides (OATP1A2, OATP1B1, OATP1B3, and OATP2B1).

  2024cites this paper
• Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms.

  2024cites this paper
• Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies.

  2024cites this paper
• Metabolite Profiling of the Gut–Renal–Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients

  2023cites this paper
• Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice

  2023cites this paper
• Selective drug delivery to the retinal cells: Biological barriers and avenues.

  2023cites this paper
• Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs.

  2023cites this paper
• Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery

  2022cites this paper
• Recent research progress of biologically active peptides

  2022cites this paper
• Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.

  2022cites this paper
• Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP transporters.

  2022cites this paper
• Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

  2022cites this paper
• Transport Mechanisms at the Blood–Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs

  2022cites this paper
• Cloning and characterization of a novel functional organic anion transporting polypeptide 3A1 isoform highly expressed in the human brain and testis

  2022cites this paper
• Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects

  2022cites this paper
• Characterization of the blood–brain barrier in genetically diverse laboratory mouse strains

  2021cites this paper
• Role of Membrane Transporters in Drug Disposition

  2021cites this paper
• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

  2021cites this paper
• Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications

  2021influential citation
• Constituents of Passiflora incarnata, but Not of Valeriana officinalis, Interact with the Organic Anion Transporting Polypeptides (OATP)2B1 and OATP1A2

  2021cites this paper
• OATP2B1 - the underrated member of the Organic Anion Transporting Polypeptide Family of drug transporters?

  2021cites this paper
• Drug Interactions in the Liver

  2020cites this paper
• Drugs and hepatic transporters: A review.

  2020cites this paper
• Structural dissection of 13-epiestrones based on the interaction with human Organic anion-transporting polypeptide, OATP2B1.

  2020cites this paper
• A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.

  2020cites this paper
• OATP1A2 and OATP2B1 are interacting with dopamine receptor agonists and antagonists.

  2020cites this paper
• Non-Human Primate Blood–Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model

  2020cites this paper
• Mechanistic modelling of in vitro transporter processes to improve drug-drug interaction predictions

  2019cites this paper
• SLC Family Transporters.

  2019cites this paper
• Organic anion transporting polypeptide 2B1 – More than a glass‐full of drug interactions

  2019cites this paper
• Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics

  2019influential citation
• Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen

  2019cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• Chicken Organic Anion-Transporting Polypeptide 1A2, a Novel Avian Hepatitis E Virus (HEV) ORF2-Interacting Protein, Is Involved in Avian HEV Infection

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• Blood-Brain Barrier: From Physiology to Disease and Back.

  2019cites this paper
• Roles of Drug Transporters in Blood-Retinal Barrier

  2019cites this paper
• Transporters in the Mammary Gland—Contribution to Presence of Nutrients and Drugs into Milk

  2019cites this paper
• Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease

  2019cites this paper
• A novel fluorescence‐based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third‐generation P‐gp inhibitors and OATP1A2

  2019cites this paper
• Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1

  2018cites this paper
• Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems.

  2018cites this paper
• Hyperglycemia Alters Expression of Cerebral Metabolic Genes after Cardiac Arrest.

  2018cites this paper
• Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters

  2018cites this paper
• Pericyte Influence on Drug Delivery Across the Blood-Brain Barrier : Implications for Therapy of Neurodegenerative Diseases

  2018cites this paper
• The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters

  2018cites this paper
• Recent advances in drug and nutrient transport across the blood-retinal barrier

  2018cites this paper
• Interactions of aliskiren, a direct renin inhibitor, with antiepileptic drugs in the test of maximal electroshock in mice

  2018cites this paper
• Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

  2018cites this paper
• Membrane Transporters Contributing to PGE2 Distribution in Central Nervous System.

  2018cites this paper
• Effect of Rifampicin on the Distribution of [11C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice.

  2018cites this paper
• The 5′-AMP-Activated Protein Kinase Regulates the Function and Expression of Human Organic Anion Transporting Polypeptide 1A2

  2018cites this paper
• Surface modified cubosomes for drug delivery across the blood-brain barrier

  2018cites this paper
• Efflux proteins at the blood–brain barrier: review and bioinformatics analysis

  2018cites this paper
• Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer’s disease drug candidates

  2017cites this paper
• SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers

  2017cites this paper
• The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions

  2017influential citation
• Morphological, functional and immunomodulatory effects of rosuvastatin and aspirin in cultured microglial cells

  2017cites this paper
• Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition☆

  2017cites this paper
• Characterization of the membrane transporter OATP1A2 activity towards different classes of drugs

  2017cites this paper
• Expression, activity and pharmacokinetic impact of ocular transporters☆

  2017cites this paper
• Perspectives of In Vivo Bioluminescence Imaging: Application to Basic and Translational Neuroscience.

  2017cites this paper
• Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?

  2017cites this paper
• Membrane Transporters in Physiological Barriers of Pharmacological Importance.

  2016cites this paper
• Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2.

  2016cites this paper
• Expression of OATP1A2 in red blood cells and its potential impact on antimalarial therapy

  2016cites this paper
• siRNA capsulated brain-targeted nanoparticles specifically knock down OATP2B1 in mice: a mechanism for acute morphine tolerance suppression

  2016cites this paper
• The neuroprotective effect of latanoprost acts via klotho‐mediated suppression of calpain activation after optic nerve transection

  2016cites this paper
• Interaction of atorvastatin with the human glial transporter SLC16A1.

  2016cites this paper
• Expression of Organic Anion Transporting Polypeptide 1A2 in Red Blood Cells and Its Potential Impact on Antimalarial Therapy

  2016cites this paper
• Functional Characterization of Carrier-Mediated Transport of Pravastatin across the Blood-Retinal Barrier in Rats

  2015cites this paper
• SLCO1A2-MDCKII: a Promising in vitro System to Understand the Role of OATP1A2 in Blood Brain Barrier Drug Penetration

  2015cites this paper
• Hyperglycemia in Experimental Cerebral Ischemia

  2015cites this paper
• SLCO 1 A 2-MDCKII : a Promising in vitro System to Understand the Role of OATP 1 A 2 in Blood Brain Barrier Drug Penetration

  2015influential citation
• Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug

  2015cites this paper
• Drug Transporters in the Central Nervous System

  2015influential citation
• Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2– Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration

  2015cites this paper
• Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all‐trans‐retinol in human retinal pigmented epithelial cells

  2015influential citation
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1089 Hyperglycemia in Experimental Cerebral Ischemia

  2015cites this paper